Source-grounded facts extracted from Bowhead Specialty Holdings Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Bowhead Specialty Holdings Inc. shareholders approved Ratification of Appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm at the 2026-04-30 meeting.
“Votes For Votes Against Abstentions Broker Non-Votes 29,863,133 839 7,398 0”
Bowhead Specialty Holdings Inc. shareholders approved Election of Class II Directors at the 2026-04-30 meeting.
“Name For Withheld Broker Non-Votes Zhak Cohen 27,572,534 165,104 2,133,732 David Foy 27,515,222 222,416 2,133,732 David Holman 20,360,433 7,377,205 2,133,732 Price Lowenstein 27,662,600 75,038 2,133,732”
Bowhead Specialty Holdings Inc. reported first quarter ended March 31, 2026 results: net income $16.0 million, EPS $0.48 per diluted share.
“Bowhead Specialty Holdings Inc. (NYSE: BOW), today announced financial results for the first quarter ended March 31, 2026. (1) First Quarter 2026 Highlights • Gross written premiums increased 24.0% to $216.7 million. • Net income of $16.0 million, or $0.48 per diluted share.”
Bowhead Specialty Holdings Inc. amended Amended and Restated Insurance Trust Agreement with American Family Mutual Insurance Company, S.I.; U.S. Bank National Association valued at Trust Amendment amends collateralization requirements to reflect increased collateralization require (effective 2026-05-04).
“On May 4, 2026, BICI, AFMIC and US Bank National Association entered into Amendment No. 1 (the “Trust Amendment”) to the Amended and Restated Insurance Trust Agreement, dated as of May 23, 2024, among BICI, AFMIC and U.S. Bank National Association, as trustee (the “Amended and Restated Trust Agreement”).”
Bowhead Specialty Holdings Inc. amended Amended and Restated Quota Share Reinsurance Agreement with American Family Mutual Insurance Company, S.I. valued at Amendment modifies termination threshold, notice period, ceding commission, and collateralization re (effective 2026-05-04).
“On May 4, 2026, Bowhead Insurance Company, Inc. (“BICI”), a wholly-owned subsidiary of Bowhead Specialty Holdings Inc., (the “Company”), entered into Amendment No. 1 (the “Amendment”) to the Amended and Restated Quota Share Reinsurance Agreement, dated as of May 23, 2024, between American Family Mutual Insurance Company, S.I. (“AFMIC”), and the Company (the “Amended and Restated Quota Share Agreement”).”
Bowhead Specialty Holdings Inc. entered into Credit Agreement with PNC Bank, National Association, as administrative agent, and the lenders and issuing banks party from time to time valued at $35 million (effective 2025-11-26).
“On November 26, 2025 (the “Effective Date”), Bowhead Specialty Holdings Inc. (the “Company”), entered into a senior revolving credit agreement (the “Credit Agreement”) with the lenders and issuing banks party from time to time thereto and with PNC Bank, National Association (“PNC”), as administrative agent (the “Administrative Agent”).”
Bowhead Specialty Holdings Inc. incurred revolving credit of $35 million with PNC Bank, National Association at Term SOFR plus 1.75% or alternate base rate plus 0.75% maturing November 26, 2027.
“The Credit Agreement provides for a senior secured revolving credit facility in the aggregate principal amount of $35 million”
Bowhead Specialty Holdings Inc. terminated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent valued at Termination and repayment in full of outstanding indebtedness under Credit Agreement dated April 22, (effective 2025-11-25).
“Concurrently with the closing of the Notes Offering, the Company terminated and repaid in full all outstanding indebtedness and other obligations due under the Credit Agreement, dated April 22, 2024 (as amended, restated, supplemented or otherwise modified from time to time), among the Company, certain subsidiaries of the Company from time to time party thereto, as guarantors, the lenders and issuing banks from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent (such payoff and termination, the “Payoff”).”
Bowhead Specialty Holdings Inc. entered into Indenture (Base Indenture and First Supplemental Indenture) with U.S. Bank Trust Company, National Association valued at Indenture for $150,000,000 7.750% Senior Notes due 2030 (effective 2025-11-25).
“The Notes were issued pursuant to an indenture, dated as of November 25, 2025 (the “Base Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), as supplemented by a First Supplemental Indenture, dated as of November 25, 2025 (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), between the Company and the Trustee.”
Bowhead Specialty Holdings Inc. entered into Underwriting Agreement with Keefe, Bruyette & Woods, Inc. and Piper Sandler & Co. valued at Underwriting Agreement for $150,000,000 7.750% Senior Notes due 2030 (effective 2025-11-20).
“In connection with the Notes Offering, the Company entered into an underwriting agreement, dated November 20, 2025, among the Company and Keefe, Bruyette & Woods, Inc. and Piper Sandler & Co., as representatives of the several underwriters named therein (the “Underwriting Agreement”).”
Dr. Ava Schnidman was elected as Director at Bowhead Specialty Holdings Inc..
“On October 30, 2024, the Board elected Dr. Ava Schnidman to the Board, effective October 30, 2024.”
Jack Stein resigned as Director at Bowhead Specialty Holdings Inc..
“Effective October 25, 2024, Jack Stein, who was one of GPC Partners Investments (SPV III) LP’s (“GPC Fund”) nominees to the board of directors (the “Board”) of Bowhead Specialty Holdings Inc. (the “Company”) pursuant to GPC Fund’s rights under the Board Nominee Agreement, dated as of May 23, 2024, between the Company and GPC Fund, resigned from the Board.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.